We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Vortioxetine Diamine Impurity
N-Nitroso Vortioxetine Diamine Impurity
CAT No SRC-N0143233
CAS No NA
Mol.F. C16H19N3OS
Mol.Wt. 301.41 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso 4-Hydroxymethyl Vortioxetine
N-Nitroso 4-Hydroxymethyl Vortioxetine
CAT No SRC-N0143234
CAS No NA
Mol.F. C18H21N3O2S
Mol.Wt. 343.45 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Vortioxetine Hydroxy Metabolite
N-Nitroso Vortioxetine Hydroxy Metabolite
CAT No SRC-N0143235
CAS No NA
Mol.F. C18H21N3O2S
Mol.Wt. 343.45 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Zafirlukast
N-Nitroso Zafirlukast
CAT No SRC-N0143236
CAS No NA
Mol.F. C31H32N4O7S
Mol.Wt. 604.68 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Decyclopentyl Zafirlukast Methyl Ester
N-Nitroso Decyclopentyl Zafirlukast Methyl Ester
CAT No SRC-N0143237
CAS No NA
Mol.F. C27H26N4O7S
Mol.Wt. 550.59 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Zafirlukast Impurity 1
N-Nitroso Zafirlukast Impurity 1
CAT No SRC-N0143238
CAS No NA
Mol.F. C46H48N6O9S
Mol.Wt. 860.98 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Zafirlukast Impurity 2
N-Nitroso Zafirlukast Impurity 2
CAT No SRC-N0143239
CAS No NA
Mol.F. C47H47N5O11S2
Mol.Wt. 922.04 g/mol
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Clemastine
N-Nitroso Clemastine
CAT No SRC-N0143240
CAS No NA
Mol.F. C20H23ClN2O2
Mol.Wt. 358.9 g/mole
INV STATUS UNDER SYNTHESIS
Clemastine Nitrosamine Impurity 1
Clemastine Nitrosamine Impurity 1
CAT No SRC-N0143241
CAS No NA
Mol.F. C6H12N2O2
Mol.Wt. 144.2 g/mole
INV STATUS UNDER SYNTHESIS
Clemastine Nitrosamine Impurity 2
Clemastine Nitrosamine Impurity 2
CAT No SRC-N0143242
CAS No NA
Mol.F. C20H23ClN2O2
Mol.Wt. 358.9 g/mole
INV STATUS UNDER SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.